MedinCell S.A.
MDCLFOTCHealthcare● Active
$34.39
+$0.00(+0.00%)
Market Cap$1.2B
P/E Ratio—
52W High$34.39
52W Low$6.9757
MedinCell S.A.（MDCLF）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · MDCLF · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $71.90M | $19.46M | $6.47M | $26.59M | $49.87M |
| Net Receivables | $3.21M | $2.27M | $2.10M | $0.82M | $0.92M |
| Inventory | $0.00M | ($0.02M) | $0.76M | $0.00M | $0.00M |
| Total Current Assets | $80.62M | $27.26M | $19.57M | $34.07M | $56.33M |
| PP&E Net | $5.27M | $5.43M | $6.37M | $7.03M | $3.85M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $2.65M | $2.45M | $1.93M | $1.67M | $1.49M |
| Total Assets | $90.45M | $36.95M | $29.34M | $44.30M | $63.61M |
| Liabilities | |||||
| Short-Term Debt | $6.62M | $5.52M | $42.81M | $27.76M | $3.18M |
| Accounts Payable | $4.00M | $1.85M | $3.59M | $2.98M | $2.96M |
| Total Current Liabilities | $29.87M | $16.47M | $57.02M | $38.24M | $13.60M |
| Long-Term Debt | $49.41M | $50.54M | $11.71M | $16.25M | $39.07M |
| Total Liabilities | $106.82M | $77.77M | $71.63M | $57.67M | $54.69M |
| Stockholders Equity | |||||
| Retained Earnings | ($18.44M) | ($25.04M) | ($32.01M) | ($24.81M) | ($19.02M) |
| Total Stockholders Equity | ($16.37M) | ($40.82M) | ($42.29M) | ($13.37M) | $8.92M |
| Total Liab & Equity(computed) | $90.45M | $36.95M | $29.34M | $44.30M | $63.61M |
| Debt Summary | |||||
| Total Debt | $58.76M | $58.96M | $57.71M | $47.49M | $43.34M |
| Net Debt | ($0.28M) | $39.50M | $51.24M | $22.88M | ($3.75M) |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · EUR · M
深入了解MedinCell S.A.
关于MedinCell S.A.（MDCLF）资产负债表
MedinCell S.A.总资产$0.09B，现金及短期投资$0.07B，总负债$0.11B，总债务$0.06B，股东权益($0.02B)。
常见问题
MDCLF · 4 问MedinCell S.A.总债务$0.06B，净债务($0.00B)。
MDCLF total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10